Login with ORCID
My Channel Users Spaces Query Publish

assertion

Full identifier: http://purl.org/np/RAUrxzwrvhf4SMEHErCDEe7OaJAsfRs3zwRqFllJVQInw#assertion

Minted in Nanopublication

 RAUrxzwrvh comment approve/disapprove edit as derived nanopublication

This is the identifier for the assertion of this nanopublication. http://purl.org/np/RAUrxzwrvh...#assertion The assertion above http://www.w3.org/ns/prov#generatedAtTime
generatedAtTime
(this is a literal)
"2022-10-13T12:08:46.697156"
(xsd:dateTime) .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAUrxzwrvh...#sig
sig
http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAUrxzwrvh... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAUrxzwrvh...#sig
sig
http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal)
"RSA"
.

Elif Ozkan, 13 Oct 2022, 12:08:46 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Elif Ozkan
2022-10-13T12:08:46.697Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
2022-10-13T12:08:46.697156
Elif Ozkan
2022-10-13T12:08:46.697Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Indevimab is used only with casirivimab to prevent COVID-19 from laboratory-confirmed SARS-CoV-2 infection in patients aged 12 years of age and older who weigh at least 40 kg. Treatment is reserved for patients who are at high risk for progressing to require hospitalization or severe treatment. This combination may only be administered by intravenous infusion in healthcare settings with immediate access to treatment.
Elif Ozkan
2022-10-13T12:08:46.697Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)